Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 1,474 | 1,092 | 1,315 | 913 | 1,279 |
| Operating Income | -1,474 | -1,092 | -1,315 | -913 | -1,279 |
| Other Income | 0 | -1 | 0 | 0 | 0 |
| Pre-tax Income | -1,474 | -1,093 | -1,315 | -913 | -1,279 |
| Net Income Continuous | -1,474 | -1,093 | -1,315 | -913 | -1,279 |
| Net Income | $-1,474 | $-1,093 | $-1,315 | $-913 | $-1,279 |
| EPS Basic Total Ops | -4.20 | -3.20 | -4.20 | -3.00 | -4.40 |
| EPS Basic Continuous Ops | -4.29 | -3.25 | -4.20 | -3.06 | -4.36 |
| EPS Diluted Total Ops | -4.20 | -3.20 | -4.20 | -3.00 | -4.40 |
| EPS Diluted Continuous Ops | -4.29 | -3.25 | -4.20 | -3.06 | -4.36 |
| EBITDA(a) | $-1,474 | $-1,092 | $-1,315 | $-913 | $-1,279 |